Inflammatory Markers in Women with Polycystic Ovary Syndrome

被引:74
|
作者
Rudnicka, E. [1 ]
Kunicki, M. [1 ,2 ]
Suchta, K. [3 ]
Machura, P. [3 ]
Grymowicz, M. [1 ]
Smolarczyk, R. [1 ]
机构
[1] Med Univ Warsaw Poland, Clin Gynecol Endocrinol, Warsaw, Poland
[2] Invicta Infertil Ctr, Warsaw, Poland
[3] Karowa Hosp, Dept Gynecol Endocrinol, Warsaw, Poland
关键词
GRADE CHRONIC INFLAMMATION; HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; PCOS; INTERLEUKIN-6; LEUKOCYTES; ANDROGENS; CRITERIA; OBESITY; RISK;
D O I
10.1155/2020/4092470
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation to be of uncertain cause: obesity, insulin resistance, or PCOS itself. The aim of the study was to investigate the WBC (white blood cell) count and CRP (C-reactive protein) concentration in women with PCOS and to determine the factors that affect their concentration. The study included 200 women aged 18-40 with PCOS and 105 healthy women as the control group, recruited in the Department of Gynaecological Endocrinology of Medical University in Warsaw from 2016 to 2018. Each patient underwent clinical, biochemical, and ultrasonographic assessments. WBC and CRP were significantly higher in the PCOS group (Z=-2,353, p=0,019 and Z=-2,453, p=0,014). WBC positively correlated with serum insulin at 0, 60, and 120 min during the oral glucose tolerance test (INS0: r=0,221, p=0,001; INS1: r=0,194, p=0,003; INS2: r=0,022, p=0,001), testosterone (r=0,130, p=0,046), androstenedione (r=0,212, p=0,001), and DHEAS (r=0,178, p=0,006) and negatively correlated with progesterone (r=-0,204, p=0,002), estradiol (r=-0,140, p=0,032), and SHBG (r=-0,308, p<0,001). CRP positively correlated with insulin concentration in 0, 60, and 120 min during the oral glucose tolerance test (INS0: r=0,343, p<0,001; INS1: r=0,276, p=0,001; INS2: r=0,320, p<001) and negatively correlated with progesterone (r=-0,194, p=0,030) and SHBG (-0,244, p=0,005). We also estimated positive correlation between BMI and serum CRP and WBC concentration. Multiple linear regression analysis showed that CRP values are positively associated with BMI (beta=0,374, p<0,001) and insulin level (INS1) (beta=0,282, p=0,004); and WBC results are negatively associated with SHGB (beta=-0,284, p<0,001) but positively associated with testosterone (beta=0,163, p=0,024) and BMI (beta=0,157, p=0,047). PCOS is associated with increased WBC and CRP concentrations. The main predicting factors of increased CRP are BMI and insulin resistance, but there is also a relationship between WBC count in PCOS and androgen concentration itself so that inflammation may be mediated not only through adiposity but also through increased androgen concentration.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Relationship of Ovarian Markers to Androgen Production in Women with Polycystic Ovary Syndrome
    Maas, Kevin
    Chuan, Sandy Shuai-Ju
    Phung, Kevin
    Hou, Jingwen
    Duleba, Antoni J.
    Chang, R. Jeffrey
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [32] The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
    Dawson, Alison J.
    Sathyapalan, Thozhukat
    Vince, Rebecca
    Coady, Anne-Marie
    Ajjan, Ramzi A.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [33] Polycystic ovary syndrome: Endometrial markers
    Piltonen, Terhi T.
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2016, 37 : 66 - 79
  • [34] Inflammatory cytokines and chemokines are elevated in women with polycystic ovary syndrome (PCOS)
    Salazar, Maria D.
    Ota, Kuniaki
    Sung, Nayoung
    Wu, Li
    Skariah, Annie
    Dambaeva, Svetlana
    Beaman, Kenneth
    Gilman-Sachs, Alice
    Kwak-Kim, Joanne
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2016, 115 : 80 - 80
  • [35] Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS)
    Giallauria, Francesco
    Palomba, Stefano
    De Sio, Ilario
    Maresca, Luigi
    Vuolo, Laura
    Savastano, Silvia
    Lombardi, Gaetano
    Colao, Annamaria
    Vigorito, Carlo
    Orio, Francesco
    [J]. CLINICAL ENDOCRINOLOGY, 2009, 70 (03) : 394 - 400
  • [36] The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome
    Souza dos Santos, Ana Celly
    Soares, Nayara Pereira
    Costa, Eduardo Caldas
    Ferrezini de Sa, Joceline Cassia
    Azevedo, George Dantas
    Araujo Moura Lemos, Telma Maria
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (03) : 225 - 228
  • [37] Vascular risk in young women with polycystic ovary and polycystic ovary syndrome
    Battaglia, Cesare
    Mancini, Fulvia
    Cianciosi, Arianna
    Busacchi, Paolo
    Facchinetti, Fabio
    Marchesini, Giulio Reggiani
    Marzocchi, Rebecca
    de Aloysio, Domenico
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 385 - 395
  • [38] Inflammatory Responses of Women with Polycystic Ovary Syndrome in Vitro Differ from Healthy Women
    Rezayat, Fatemeh
    Hajiaghayi, Mehri
    Ghasemi, Nazanin
    Mesdaghi, Mehrnaz
    Tehrani, Fahimeh Ramezani
    Mosaffa, Nariman
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2023, 12 (01) : 70 - +
  • [39] Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome
    De Leo, Vincenzo
    Di Sabatino, Alessandra
    Musacchio, Maria C.
    Morgante, Giuseppe
    Scolaro, Valeria
    Cianci, Antonio
    Petraglia, Felice
    [J]. CONTRACEPTION, 2010, 82 (03) : 276 - 280
  • [40] Association of Tumor Markers with Total Testosterone in the Serum of Women with Polycystic Ovary Syndrome
    Zhang, Jinghua
    Pan, Manman
    Zhang, Qing
    Wang, Fangfang
    Qu, Fan
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (07):